jan 1, 1995 - FDA approves the first
protease inhibitor beginning
a new era of highly active
antiretroviral treatment (HAART).
For those countries that could
afford it, HAART would cause
a decline of 60%-80% in rates
of AIDS-related deaths and
hospitalization.